The effect of rhG-CSF on spleen transcriptome in mouse leukopenia model induced by cyclophosphamide

References

• Sicinska E, Lee YM, Gits J, et al. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes. Mol Cell Biol 2006;26:8052–8060
   PubMed Web of Science ®Google Scholar
• Kato JY, Sherr CJ. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA 1993;90:11513–11517
   PubMed Web of Science ®Google Scholar
• Marmier-Savet C, Larosa F, Legrand F, et al. Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors. Transfusion 2010;50:2676–2685
   PubMed Web of Science ®Google Scholar
• Rutella S, Pierelli L, Bonanno G, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 2002;100:2562–2571
   PubMed Web of Science ®Google Scholar
• Rutella S, Pierelli L, Rumi C, et al. T-cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp Hematol 2001;29:401–415
   PubMed Web of Science ®Google Scholar
• Klangsinsirikul P, Russell NH. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002;30:495–501
   PubMed Web of Science ®Google Scholar
• Joo YD, Lee WS, Won HJ, et al. G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation. Cytokine 2012;60:277–283
   PubMed Web of Science ®Google Scholar
• Ohta Y, Hayakawa S, Karasaki-Suzuki M, et al. Granulocyte colony-stimulating factor suppresses autologous tumor killing activity of the peripheral blood lymphocytes in the patients with ovarian carcinoma. Am J Reprod Immunol 2004;52:81–87
   PubMed Web of Science ®Google Scholar
• Schlahsa L, Jaimes Y, Blasczyk R, Figueiredo C. Granulocyte-colony-stimulatory factor: a strong inhibitor of natural killer cell function. Transfusion 2011;51:293–305
   PubMed Web of Science ®Google Scholar
• Su YC, Li SC, Hsu CK, et al. G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT. Bone Marrow Transplant 2012;47:73–81
   PubMed Web of Science ®Google Scholar
• Xu WW, Han MJ, Chen D, et al. Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processes. BMC Med Genomics 2013;6:15
   PubMed Web of Science ®Google Scholar
• Chen F, Zhu HH, Zhou LF, et al. Genes related to the very early stage of ConA-induced fulminant hepatitis: a gene-chip-based study in a mouse model. BMC Genomics 2010;11:240
   PubMed Web of Science ®Google Scholar
• van Bree SH, Gomez-Pinilla PJ, van de Bovenkamp FS, et al. Inhibition of spleen tyrosine kinase as treatment of postoperative ileus. Gut 2013;62:1581–1590
   PubMed Web of Science ®Google Scholar
• Weinstein DA, Gogal RM Jr, Mustafa A, et al. Mid-gestation exposure of C57BL/6 mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes postnatal morphologic changes in the spleen and liver. Toxicol Pathol 2008;36:705–713
   PubMed Web of Science ®Google Scholar
• Ludeman SM. The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 1999;5:627–643
   PubMed Web of Science ®Google Scholar
• Malayappan B, Johnson L, Nie B, et al. Quantitative high-performance liquid chromatography-electrospray ionization tandem mass spectrometry analysis of bis-N7-guanine DNA-DNA cross-links in white blood cells of cancer patients receiving cyclophosphamide therapy. Anal Chem 2010;82:3650–3658
   PubMed Web of Science ®Google Scholar
• Erickson LC, Ramonas LM, Zaharko DS, Kohn KW. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Cancer Res 1980;40:4216–4220
   PubMed Web of Science ®Google Scholar
• Mirkes PE. Cyclophosphamide teratogenesis: a review. Teratog Carcinog Mutagen 1985;5:75–88
   PubMedGoogle Scholar
• Kaur J, Catovsky D, Spiers AS, Galton DA. Increase of T lymphocytes in the spleen in chronic granulocytic leukaemia. Lancet 1974;1:834–836
   PubMed Web of Science ®Google Scholar
• Felsberg J, Thon N, Eigenbrod S, et al. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer 2011;129:659–670
   PubMed Web of Science ®Google Scholar
• Schaetzlein S, Chahwan R, Avdievich E, et al. Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes. Proc Natl Acad Sci USA 2013;110:E2470–E2479
   PubMed Web of Science ®Google Scholar
• Chun J, Buechelmaier ES, Powell SN. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol Cell Biol 2013;33:387–395
   PubMed Web of Science ®Google Scholar
• Pedersen BS, Konstantinopoulos PA, Spillman MA, De S. Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients. Genes Chromosomes Cancer 2013;52:794–801
   PubMed Web of Science ®Google Scholar
• Rodrigue A, Coulombe Y, Jacquet K, et al. The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. J Cell Sci 2013;126:348–359
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wani G, Sharma N, Wani A. Lack of CAK complex accumulation at DNA damage sites in XP-B and XP-B/CS fibroblasts reveals differential regulation of CAK anchoring to core TFIIH by XPB and XPD helicases during nucleotide excision repair. DNA Repair (Amst) 2012;11:942–950
   PubMed Web of Science ®Google Scholar
• Slyskova J, Korenkova V, Collins AR, et al. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. Clin Cancer Res 2012;18:5878–5887
   Google Scholar
• Goldstein M, Roos WP, Kaina B. Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling. Toxicol Appl Pharmacol 2008;229:20–32
   PubMed Web of Science ®Google Scholar
• Schwartz PS, Waxman DJ. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol 2001;60:1268–1279
   PubMed Web of Science ®Google Scholar
• Chow LW, Loo WT. The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein (p21(WAF-1)) and anti-apoptotic protein (bcl-2) in breast cancer cells. Breast Cancer Res Treat 2003;80:239–244
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang R. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Int J Oncol 1998;12:793–804
   PubMed Web of Science ®Google Scholar
• Almond JB, Cohen GM. The proteasome: a novel target for cancer chemotherapy. Leukemia 2002;16:433–443
   PubMed Web of Science ®Google Scholar
• Ghanem L, Steinman RA. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells. Leuk Res 2006;30:1285–1292
   PubMed Web of Science ®Google Scholar
• Ishida K, Yuge Y, Hanaoka M, et al. Gadd45g regulates dental epithelial cell proliferation through p38 MAPK-mediated p21 expression. Genes Cells 2013;18:660–671
   PubMed Web of Science ®Google Scholar
• Ullmannova V, Stockbauer P, Hradcova M, et al. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk Res 2003;27:1115–1123
   PubMed Web of Science ®Google Scholar
• Hadaya K, Kared H, Masson A, et al. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J Autoimmun 2005;24:125–134
   PubMed Web of Science ®Google Scholar
• Gorgen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 1992;149:918–924
   PubMed Web of Science ®Google Scholar
• Zavala F, Abad S, Ezine S, et al. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J Immunol 2002;168:2011–2019
   PubMed Web of Science ®Google Scholar
• Morris ES, MacDonald KP, Rowe V, et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 2004;103:3573–3581
   PubMed Web of Science ®Google Scholar
• Rutella S. Granulocyte colony-stimulating factor for the induction of T-cell tolerance. Transplantation 2007;84:S26–S30
   PubMed Web of Science ®Google Scholar
• Rutella S, Zavala F, Danese S, et al. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 2005;175:7085–7091
   PubMed Web of Science ®Google Scholar
• Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 2006;17:235–244
   PubMed Web of Science ®Google Scholar
• Rutella S, Bonanno G, Pierelli L, et al. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004;34:1291–1302
   PubMed Web of Science ®Google Scholar
• Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006;108:1435–1440
   PubMed Web of Science ®Google Scholar
• Carion A, Domenech J, Herault O, et al. Decreased stroma adhesion capacity of CD34+ progenitor cells from mobilized peripheral blood is not lineage- or stage-specific and is associated with low beta 1 and beta 2 integrin expression. J Hematother Stem Cell Res 2002;11:491–500
   PubMedGoogle Scholar
• Engl T, Relja B, Marian D, et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006;8:290–301
   PubMed Web of Science ®Google Scholar
• Gold ES, Underhill DM, Morrissette NS, et al. Dynamin 2 is required for phagocytosis in macrophages. J Exp Med 1999;190:1849–1856
   PubMedGoogle Scholar
• Yang Y, Zhang R, Xia F, et al. LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. Exp Cell Res 2013;319:1774–1783
   PubMed Web of Science ®Google Scholar
• Oh K, Lee OY, Shon SY, et al. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Res 2013;15:R79
   PubMed Web of Science ®Google Scholar
• Bayne LJ, Vonderheide RH. A myeloid-derived suppressor cell-mediated T-cell suppression assay for functional evaluation of immune cells in tumor-bearing mice. Cold Spring Harb Protoc 2013;9:849–853
   Google Scholar
• Waight JD, Hu Q, Miller A, et al. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 2011;6:e27690
   PubMed Web of Science ®Google Scholar
• Luyckx A, Schouppe E, Rutgeerts O, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol 2012;143:83–87
   PubMed Web of Science ®Google Scholar
• Marino VJ, Roguin LP. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line. J Cell Biochem 2008;103:1512–1523
   PubMed Web of Science ®Google Scholar